Article Text

other Versions

Download PDFPDF
Original research
Endovascular treatment of intracranial aneurysms with the Woven EndoBridge device: mid term and long term results
  1. Benjamin Mine,
  2. Alexandra Goutte,
  3. Denis Brisbois,
  4. Boris Lubicz
  1. University Hospital Erasme, Interventional Neuroradiology, Brussels, Belgium
  1. Correspondence to Dr B Mine, University Hospital Erasme, Interventional Neuroradiology, Route de Lennik 808, Brussels 1070, Belgium; Benjamin_Mine{at}me.com

Abstract

Purpose To evaluate the clinical and anatomical results of treatment of intracranial aneurysms (IA) with the Woven EndoBridge (WEB) device, with emphasis on mid term and long term follow-up.

Methods Between November 2010 and November 2015, we retrospectively identified, in our prospectively maintained database, all patients treated by WEB device placement for an IA at three institutions. Clinical charts, procedural data, and angiographic results were reviewed.

Results 48 patients with 49 IAs were identified. There were 35 women and 13 men with a mean age of 57 years (range 35–76 years). All IA were wide necked. Mean aneurysm size was 8.6 mm. There were 44 unruptured IA and 5 ruptured IA. During endovascular treatment (EVT), adjunctive devices were used in 22.4% of procedures. A good clinical outcome (modified Rankin Scale score ≤2) was achieved in 44/48 patients (92%). There was no mortality. Mean follow-up was 25 months (range 3–72 months; median 24 months). Between mid term and long term follow-up, occlusion was stable in 19/23 IA (82.6%), improved in 2/23 IA (8.7%), and worsened in 2/23 IA (8.7%). Retreatment was performed in 8/49 IA (16.3%). At the latest available follow-up, there were 34/47 (72.3%) complete occlusions and 13/47 (27.7%) neck remnants.

Conclusions Our study suggests that EVT of IA with the WEB device provides adequate and stable long term occlusion.

  • Aneurysm
  • Device

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors BM, AG, DB, and BL: substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published;and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

  • Competing interests None declared.

  • Ethics approval The study was approved by the ethics committee of Erasme University Hospital.

  • Provenance and peer review Not commissioned; externally peer reviewed.